Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
2.09
Jul. 26, 2024 16:00:00- Change -0.01 (-0.4762%)
- Volume 12,830
- Today's Open 2.13
- Previous Close 2.1
- Today's High 2.13
- Today's Low 2.01
- 52 Week High 6.789
- 52 Week Low 1.57